DE69310353D1 - 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze - Google Patents
2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalzeInfo
- Publication number
- DE69310353D1 DE69310353D1 DE69310353T DE69310353T DE69310353D1 DE 69310353 D1 DE69310353 D1 DE 69310353D1 DE 69310353 T DE69310353 T DE 69310353T DE 69310353 T DE69310353 T DE 69310353T DE 69310353 D1 DE69310353 D1 DE 69310353D1
- Authority
- DE
- Germany
- Prior art keywords
- tetrahydro
- benzazepine
- acid addition
- addition salts
- pharmaceutically compatible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- MWVMYAWMFTVYED-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1CNCCC2=CC=CC=C21 MWVMYAWMFTVYED-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK92233A DK23392D0 (da) | 1992-02-24 | 1992-02-24 | Heterocykliske forbindelser, deres anvendelse og fremstilling |
PCT/DK1993/000041 WO1993017012A1 (en) | 1992-02-24 | 1993-02-05 | 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69310353D1 true DE69310353D1 (de) | 1997-06-05 |
DE69310353T2 DE69310353T2 (de) | 1997-10-02 |
Family
ID=8091236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69310353T Expired - Fee Related DE69310353T2 (de) | 1992-02-24 | 1993-02-05 | 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0628039B1 (de) |
JP (1) | JPH07504172A (de) |
KR (1) | KR100255739B1 (de) |
AT (1) | ATE152450T1 (de) |
AU (1) | AU667878B2 (de) |
BG (1) | BG62208B1 (de) |
CA (1) | CA2130678C (de) |
CZ (1) | CZ288626B6 (de) |
DE (1) | DE69310353T2 (de) |
DK (2) | DK23392D0 (de) |
ES (1) | ES2102019T3 (de) |
FI (1) | FI113770B (de) |
GR (1) | GR3023896T3 (de) |
HU (1) | HU221314B1 (de) |
IL (1) | IL104657A (de) |
NO (1) | NO310193B1 (de) |
NZ (1) | NZ249465A (de) |
RO (1) | RO116088B1 (de) |
RU (1) | RU2114839C1 (de) |
SK (1) | SK281390B6 (de) |
UA (1) | UA34451C2 (de) |
WO (1) | WO1993017012A1 (de) |
ZA (1) | ZA931099B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1945495A (en) * | 1994-03-16 | 1995-10-03 | Novo Nordisk A/S | Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
HUP9900746A3 (en) * | 1995-09-15 | 1999-11-29 | Cenes Ltd Histon | Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds, process for their preparation and pharmaceutical compositions containing the same |
GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
ES2401319T3 (es) * | 2002-12-20 | 2013-04-18 | Glaxo Group Limited | Nuevo derivado de benzazepina |
EP3842420B1 (de) | 2012-10-25 | 2022-12-07 | Tetra Discovery Partners LLC | Heteroaryl-inhibitoren von pde4 |
US20150086480A1 (en) * | 2013-09-26 | 2015-03-26 | Tetra Discovery Partners, LLC | Heteroaryl inhibitors of pde4 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
DK325188D0 (da) * | 1988-06-15 | 1988-06-15 | Novo Industri As | Hidtil ukendte benzazepinderivater |
DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
-
1992
- 1992-02-24 DK DK92233A patent/DK23392D0/da not_active Application Discontinuation
-
1993
- 1993-02-05 CZ CZ19941988A patent/CZ288626B6/cs not_active IP Right Cessation
- 1993-02-05 DE DE69310353T patent/DE69310353T2/de not_active Expired - Fee Related
- 1993-02-05 NZ NZ249465A patent/NZ249465A/en unknown
- 1993-02-05 HU HU9402434A patent/HU221314B1/hu not_active IP Right Cessation
- 1993-02-05 AU AU36265/93A patent/AU667878B2/en not_active Ceased
- 1993-02-05 CA CA002130678A patent/CA2130678C/en not_active Expired - Fee Related
- 1993-02-05 SK SK1000-94A patent/SK281390B6/sk unknown
- 1993-02-05 AT AT93905215T patent/ATE152450T1/de not_active IP Right Cessation
- 1993-02-05 UA UA94085741A patent/UA34451C2/uk unknown
- 1993-02-05 WO PCT/DK1993/000041 patent/WO1993017012A1/en active IP Right Grant
- 1993-02-05 DK DK93905215.5T patent/DK0628039T3/da active
- 1993-02-05 KR KR1019940702944A patent/KR100255739B1/ko not_active Expired - Fee Related
- 1993-02-05 JP JP5514460A patent/JPH07504172A/ja active Pending
- 1993-02-05 EP EP93905215A patent/EP0628039B1/de not_active Expired - Lifetime
- 1993-02-05 RU RU94040719A patent/RU2114839C1/ru not_active IP Right Cessation
- 1993-02-05 RO RO94-01400A patent/RO116088B1/ro unknown
- 1993-02-05 ES ES93905215T patent/ES2102019T3/es not_active Expired - Lifetime
- 1993-02-09 IL IL10465793A patent/IL104657A/en not_active IP Right Cessation
- 1993-02-17 ZA ZA931099A patent/ZA931099B/xx unknown
-
1994
- 1994-08-22 BG BG98993A patent/BG62208B1/bg unknown
- 1994-08-23 FI FI943875A patent/FI113770B/fi not_active IP Right Cessation
- 1994-08-24 NO NO19943123A patent/NO310193B1/no not_active IP Right Cessation
-
1997
- 1997-06-26 GR GR970401543T patent/GR3023896T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI941378A0 (fi) | Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus | |
DE69232334D1 (de) | Substituierte 3-aminochinuclidine | |
PH25571A (en) | Alpha'-alkyl-4-amino-3-quinolinemethanols, 1-(4-aralkylamino-3-quinolinyl) alaknones, their use as medicaments | |
ATE206708T1 (de) | Benzimidazolonderivate mit zentraler dopaminerger aktivität | |
FI970469A0 (fi) | Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus | |
DE69310353D1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze | |
TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
FI865220A0 (fi) | Foerfarande foer framstaellning av sulfinyl- och sulfonylsubstituerade 3-benzazepiner. | |
ATE89553T1 (de) | Hydroxy-1,2,3,4-tetrahydroaminoacridine, verfahren fuer ihre herstellung und ihre verwendung als arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: CENES LTD., CAMBRIDGE, GB |
|
8339 | Ceased/non-payment of the annual fee |